Market Overview:
The global Tramadol Hydrochloride market is expected to grow at a CAGR of 3.8% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of chronic pain, increasing demand for Tramadol Hydrochloride in Asia Pacific and Middle East & Africa, and growing awareness about the benefits of Tramadol Hydrochloride. However, stringent regulatory norms and side effects associated with Tramadol Hydrochloride are likely to restrain the growth of this market during the forecast period. Based on type, the global Tramadol Hydrochloride market can be segmented into purity: 99%, purity: >99%, and others. The purity: 99% segment is expected to account for a major share of the global Tramadol Hydrochloride market during the forecast period owing to its high demand among consumers.
Product Definition:
Tramadol Hydrochloride is a synthetic opioid analgesic used to treat moderate to severe pain. It is a centrally acting analgesic that works by binding to the mu-opioid receptor in the brain and spinal cord. Tramadol Hydrochloride also inhibits norepinephrine and serotonin reuptake, which may contribute to its analgesic effects.
Purity:99%:
Purity:99% is a crystalline form of Tramadol, which has been analyzed through several tests and research to be more potent than the original drug. The company that created this product, Pfizer Inc., registered it under the name Ultram (tramadol) as an OTC drug in the U.S., making it one of the first FDA-approved drugs with a purity level higher than 99%.
Purity:>99%:
Tramadol Hydrochloride is a pain-relieving drug and an opioid. It is used to treat chronic pain, as well as for the management of post-surgery pain. The drug has been found effective in treating neuropathic pain, which is caused by diabetes or other medical conditions that damage the nerves.
Purity: 99%+ means that there are no impurities present in more than 99% concentration.
Application Insights:
Based on the application, the global tramadol hydrochloride market is segmented into tablet, capsule and others. The tablet was estimated as the largest segment in 2017 owing to its high preference in pain management therapies. It is also used for moderate to severe pain where other medications have not been effective. Capsule form of Tramadol Hydrochloride is expected to be one of the fastest growing segments over the forecast period owing to its convenience and easy consumption compared with tablets or powder forms of tramadol products. Other applications include injection form which has a higher preference for treating chronic pain caused by osteoarthritis or rheumatoid arthritis as it provides faster relief than oral forms such as tablets & capsules do. However, these injections are only available in limited supply and hence limit their use across various regions around the world including North America, Europe & Asia Pacific etc.
Regional Analysis:
Asia Pacific dominated the global tramadol hydrochloride market in 2017. The presence of a large number of manufacturers coupled with increasing demand for opioid-based painkillers has resulted in high revenue generation for tramadol hydrochloride in this region. China, India, and Australia are expected to be the key markets over the forecast period owing to growing consumption rates and availability of low-cost raw materials.
The Asia Pacific is anticipated to be followed by Europe during the same period owing to rising geriatric population prone to chronic pain conditions coupled with government initiatives favoring quality medical products over quantity at any cost. Moreover, stringent regulations regarding manufacturing processes along with product quality are likely boost revenue growth during the forecast period as well as after it ends.
In North America, tramadol was first introduced into clinical use through a controlled release tablet formulation developed by Pfizer Inc., U.S., in 2004 under brand name Tramadeo (Figure 1).
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace. This is expected to drive the demand for tramadol hydrochloride in the coming years as it is one of the most commonly prescribed medications for elderly patients suffering from pain.
- Rising incidence of chronic pain: The prevalence of chronic pain is on the rise due to various factors such as lifestyle changes, obesity, and stress. This is likely to boost the demand for tramadol hydrochloride in the near future as it offers relief from chronic pain symptoms.
- Growing awareness about benefits of tramadol hydrochloride: There has been a growing awareness about the benefits of tramadol hydrochloride among both healthcare professionals and consumers in recent years. This is likely to propel its market growth in upcoming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Tramadol Hydrochloride Market Research Report
By Type
Purity:99%, Purity:>99%
By Application
Tablet, Capsule, Others
By Companies
ACIC Pharmaceuticals, Sreekara Organics, Saneca Pharma, Jubilant Pharma, Admiron Life Sciences Private Limited, Arevi Pharma, Ogene
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Tramadol Hydrochloride Market Report Segments:
The global Tramadol Hydrochloride market is segmented on the basis of:
Types
Purity:99%, Purity:>99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tablet, Capsule, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ACIC Pharmaceuticals
- Sreekara Organics
- Saneca Pharma
- Jubilant Pharma
- Admiron Life Sciences Private Limited
- Arevi Pharma
- Ogene
Highlights of The Tramadol Hydrochloride Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity:99%
- Purity:>99%
- By Application:
- Tablet
- Capsule
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tramadol Hydrochloride Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tramadol hydrochloride is a medication used to treat pain. It works by blocking the receptors in your brain that are responsible for sending signals of pain.
Some of the major companies in the tramadol hydrochloride market are ACIC Pharmaceuticals, Sreekara Organics, Saneca Pharma, Jubilant Pharma, Admiron Life Sciences Private Limited, Arevi Pharma, Ogene.
The tramadol hydrochloride market is expected to register a CAGR of 3.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Tramadol Hydrochloride Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Tramadol Hydrochloride Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Tramadol Hydrochloride Market - Supply Chain
4.5. Global Tramadol Hydrochloride Market Forecast
4.5.1. Tramadol Hydrochloride Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Tramadol Hydrochloride Market Size (000 Units) and Y-o-Y Growth
4.5.3. Tramadol Hydrochloride Market Absolute $ Opportunity
5. Global Tramadol Hydrochloride Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Tramadol Hydrochloride Market Size and Volume Forecast by Type
5.3.1. Purity:99%
5.3.2. Purity:>99%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Tramadol Hydrochloride Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Tramadol Hydrochloride Market Size and Volume Forecast by Application
6.3.1. Tablet
6.3.2. Capsule
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Tramadol Hydrochloride Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Tramadol Hydrochloride Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Tramadol Hydrochloride Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Tramadol Hydrochloride Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Tramadol Hydrochloride Demand Share Forecast, 2019-2026
9. North America Tramadol Hydrochloride Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Tramadol Hydrochloride Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Tramadol Hydrochloride Market Size and Volume Forecast by Application
9.4.1. Tablet
9.4.2. Capsule
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Tramadol Hydrochloride Market Size and Volume Forecast by Type
9.7.1. Purity:99%
9.7.2. Purity:>99%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Tramadol Hydrochloride Demand Share Forecast, 2019-2026
10. Latin America Tramadol Hydrochloride Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Tramadol Hydrochloride Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Tramadol Hydrochloride Market Size and Volume Forecast by Application
10.4.1. Tablet
10.4.2. Capsule
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Tramadol Hydrochloride Market Size and Volume Forecast by Type
10.7.1. Purity:99%
10.7.2. Purity:>99%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Tramadol Hydrochloride Demand Share Forecast, 2019-2026
11. Europe Tramadol Hydrochloride Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Tramadol Hydrochloride Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Tramadol Hydrochloride Market Size and Volume Forecast by Application
11.4.1. Tablet
11.4.2. Capsule
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Tramadol Hydrochloride Market Size and Volume Forecast by Type
11.7.1. Purity:99%
11.7.2. Purity:>99%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractivenes/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Tramadol Hydrochloride Demand Share, 2019-2026
12. Asia Pacific Tramadol Hydrochloride Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Tramadol Hydrochloride Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Tramadol Hydrochloride Market Size and Volume Forecast by Application
12.4.1. Tablet
12.4.2. Capsule
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Tramadol Hydrochloride Market Size and Volume Forecast by Type
12.7.1. Purity:99%
12.7.2. Purity:>99%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Tramadol Hydrochloride Demand Share, 2019-2026
13. Middle East & Africa Tramadol Hydrochloride Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Tramadol Hydrochloride Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Tramadol Hydrochloride Market Size and Volume Forecast by Application
13.4.1. Tablet
13.4.2. Capsule
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Tramadol Hydrochloride Market Size and Volume Forecast by Type
13.7.1. Purity:99%
13.7.2. Purity:>99%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Tramadol Hydrochloride Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Tramadol Hydrochloride Market: Market Share Analysis
14.2. Tramadol Hydrochloride Distributors and Customers
14.3. Tramadol Hydrochloride Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ACIC Pharmaceuticals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sreekara Organics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Saneca Pharma
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Jubilant Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Admiron Life Sciences Private Limited
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Arevi Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ogene
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
